Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process

Chia Chyi Liu, Hsuen Wen Chang, Grace Yang, Jen Ron Chiang, Yen Hung Chow, I. Hsi Sai, Jui Yuan Chang, Sue Chen Lin, Charles Sia, Chia Hsin Hsiao, Ai Hsiang Chou, Pele Chong

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Enterovirus 71 (EV71), the etiologic agent causes outbreaks with significant mortality in young children in Asia and currently there is no vaccine available. In this study, we report a quantitative enzyme linked immunosorbent assay (Q-ELISA) to determine the concentration of the EV71 VP2 antigen. EV71 virus-like particles (VLPs) were produced in the baculovirus expression system and used as the EV71 antigen reference standard. Antisera from both EV71-immunized chickens and rabbits were very efficient and useful as capture antibodies to bind various forms of EV71 antigens, whereas a commercial VP2-specific virus neutralizing monoclonal antibody MAB979 was found to be suitable for quantifying the amount of VP2 antigen. This Q-ELISA was used successfully to determine VP2 content at each stage of EV71 vaccine manufacturing process, particularly during the upstream harvest, downstream purification and viral inactivation steps. The amount of VP2 antigen and the magnitude of neutralizing titers were found to be dose-dependent in mice immunized with vaccine candidates. These results indicate that Q-ELISA could provide off-line timely quantitative measurements of VP2 antigen throughout the production cycle to evaluate critical attributes and conditions that may affect virus yields in culture media, the quality of purification methods, the stability and potency of final vaccine formulations.

Original languageEnglish
Pages (from-to)60-68
Number of pages9
JournalJournal of Virological Methods
Volume176
Issue number1-2
DOIs
Publication statusPublished - Sep 1 2011
Externally publishedYes

Fingerprint

Enterovirus
Vaccines
Enzyme-Linked Immunosorbent Assay
Antigens
Vaccine Potency
Virus Inactivation
Viruses
Baculoviridae
Neutralizing Antibodies
Virion
Disease Outbreaks
Culture Media
Immune Sera
Chickens
Monoclonal Antibodies
Rabbits
Mortality
Antibodies

Keywords

  • ELISA
  • Enterovirus 71
  • Neutralization epitope
  • Process analytical technology
  • Viral antigen

ASJC Scopus subject areas

  • Virology

Cite this

Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process. / Liu, Chia Chyi; Chang, Hsuen Wen; Yang, Grace; Chiang, Jen Ron; Chow, Yen Hung; Sai, I. Hsi; Chang, Jui Yuan; Lin, Sue Chen; Sia, Charles; Hsiao, Chia Hsin; Chou, Ai Hsiang; Chong, Pele.

In: Journal of Virological Methods, Vol. 176, No. 1-2, 01.09.2011, p. 60-68.

Research output: Contribution to journalArticle

Liu, CC, Chang, HW, Yang, G, Chiang, JR, Chow, YH, Sai, IH, Chang, JY, Lin, SC, Sia, C, Hsiao, CH, Chou, AH & Chong, P 2011, 'Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process', Journal of Virological Methods, vol. 176, no. 1-2, pp. 60-68. https://doi.org/10.1016/j.jviromet.2011.06.001
Liu, Chia Chyi ; Chang, Hsuen Wen ; Yang, Grace ; Chiang, Jen Ron ; Chow, Yen Hung ; Sai, I. Hsi ; Chang, Jui Yuan ; Lin, Sue Chen ; Sia, Charles ; Hsiao, Chia Hsin ; Chou, Ai Hsiang ; Chong, Pele. / Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process. In: Journal of Virological Methods. 2011 ; Vol. 176, No. 1-2. pp. 60-68.
@article{1ee8945e6d3947168c6614e76193c1b2,
title = "Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process",
abstract = "Enterovirus 71 (EV71), the etiologic agent causes outbreaks with significant mortality in young children in Asia and currently there is no vaccine available. In this study, we report a quantitative enzyme linked immunosorbent assay (Q-ELISA) to determine the concentration of the EV71 VP2 antigen. EV71 virus-like particles (VLPs) were produced in the baculovirus expression system and used as the EV71 antigen reference standard. Antisera from both EV71-immunized chickens and rabbits were very efficient and useful as capture antibodies to bind various forms of EV71 antigens, whereas a commercial VP2-specific virus neutralizing monoclonal antibody MAB979 was found to be suitable for quantifying the amount of VP2 antigen. This Q-ELISA was used successfully to determine VP2 content at each stage of EV71 vaccine manufacturing process, particularly during the upstream harvest, downstream purification and viral inactivation steps. The amount of VP2 antigen and the magnitude of neutralizing titers were found to be dose-dependent in mice immunized with vaccine candidates. These results indicate that Q-ELISA could provide off-line timely quantitative measurements of VP2 antigen throughout the production cycle to evaluate critical attributes and conditions that may affect virus yields in culture media, the quality of purification methods, the stability and potency of final vaccine formulations.",
keywords = "ELISA, Enterovirus 71, Neutralization epitope, Process analytical technology, Viral antigen",
author = "Liu, {Chia Chyi} and Chang, {Hsuen Wen} and Grace Yang and Chiang, {Jen Ron} and Chow, {Yen Hung} and Sai, {I. Hsi} and Chang, {Jui Yuan} and Lin, {Sue Chen} and Charles Sia and Hsiao, {Chia Hsin} and Chou, {Ai Hsiang} and Pele Chong",
year = "2011",
month = "9",
day = "1",
doi = "10.1016/j.jviromet.2011.06.001",
language = "English",
volume = "176",
pages = "60--68",
journal = "Journal of Virological Methods",
issn = "0166-0934",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process

AU - Liu, Chia Chyi

AU - Chang, Hsuen Wen

AU - Yang, Grace

AU - Chiang, Jen Ron

AU - Chow, Yen Hung

AU - Sai, I. Hsi

AU - Chang, Jui Yuan

AU - Lin, Sue Chen

AU - Sia, Charles

AU - Hsiao, Chia Hsin

AU - Chou, Ai Hsiang

AU - Chong, Pele

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Enterovirus 71 (EV71), the etiologic agent causes outbreaks with significant mortality in young children in Asia and currently there is no vaccine available. In this study, we report a quantitative enzyme linked immunosorbent assay (Q-ELISA) to determine the concentration of the EV71 VP2 antigen. EV71 virus-like particles (VLPs) were produced in the baculovirus expression system and used as the EV71 antigen reference standard. Antisera from both EV71-immunized chickens and rabbits were very efficient and useful as capture antibodies to bind various forms of EV71 antigens, whereas a commercial VP2-specific virus neutralizing monoclonal antibody MAB979 was found to be suitable for quantifying the amount of VP2 antigen. This Q-ELISA was used successfully to determine VP2 content at each stage of EV71 vaccine manufacturing process, particularly during the upstream harvest, downstream purification and viral inactivation steps. The amount of VP2 antigen and the magnitude of neutralizing titers were found to be dose-dependent in mice immunized with vaccine candidates. These results indicate that Q-ELISA could provide off-line timely quantitative measurements of VP2 antigen throughout the production cycle to evaluate critical attributes and conditions that may affect virus yields in culture media, the quality of purification methods, the stability and potency of final vaccine formulations.

AB - Enterovirus 71 (EV71), the etiologic agent causes outbreaks with significant mortality in young children in Asia and currently there is no vaccine available. In this study, we report a quantitative enzyme linked immunosorbent assay (Q-ELISA) to determine the concentration of the EV71 VP2 antigen. EV71 virus-like particles (VLPs) were produced in the baculovirus expression system and used as the EV71 antigen reference standard. Antisera from both EV71-immunized chickens and rabbits were very efficient and useful as capture antibodies to bind various forms of EV71 antigens, whereas a commercial VP2-specific virus neutralizing monoclonal antibody MAB979 was found to be suitable for quantifying the amount of VP2 antigen. This Q-ELISA was used successfully to determine VP2 content at each stage of EV71 vaccine manufacturing process, particularly during the upstream harvest, downstream purification and viral inactivation steps. The amount of VP2 antigen and the magnitude of neutralizing titers were found to be dose-dependent in mice immunized with vaccine candidates. These results indicate that Q-ELISA could provide off-line timely quantitative measurements of VP2 antigen throughout the production cycle to evaluate critical attributes and conditions that may affect virus yields in culture media, the quality of purification methods, the stability and potency of final vaccine formulations.

KW - ELISA

KW - Enterovirus 71

KW - Neutralization epitope

KW - Process analytical technology

KW - Viral antigen

UR - http://www.scopus.com/inward/record.url?scp=79960609635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960609635&partnerID=8YFLogxK

U2 - 10.1016/j.jviromet.2011.06.001

DO - 10.1016/j.jviromet.2011.06.001

M3 - Article

VL - 176

SP - 60

EP - 68

JO - Journal of Virological Methods

JF - Journal of Virological Methods

SN - 0166-0934

IS - 1-2

ER -